Chronic inflammation may be subtle but can indicate serious health issues. Discover common and surprising symptoms, and learn ...

Falls are common among adults with SLE and are linked to several factors, including higher disease activity, organ damage, and polypharmacy.

Autoimmune diseases are on the rise in the U.S., with as many as 50 million Americans affected. Learn what causes them—and which symptoms could help pinpoint your problem.

A popular online athleisure wear company supporting lupus research is opening their first brick-and-mortar location in ...

Obexelimab met primary endpoint with a 95% relative reduction in new gadolinium (Gd)-enhancing T1 lesions compared with placebo, p=0.0009 ...

KT-579, a potent, selective, oral degrader of IRF5, demonstrated broad activity across multiple preclinical models of lupus and rheumatoid ...

Integrated analyses of the Phase 2 PAISLEY-SLE and PAISLEY LTE studies showed that Sotyktu maintained a consistent safety profile and durable efficacy in patients with moderate-to-severe SLE with up ...

CHICAGO — Enpatoran, a first-in-class oral small molecule toll-like receptor 7/8 inhibitor, is superior to placebo in ...

Relief from lupus pain can be seen as a placeholder, not unlike that moment before a great discovery, writes columnist ...

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the U.S. Food and Drug Administration (FDA) has approved Gazyva ® (obinutuzumab) for the treatment of adult ...

Much of the evidence documenting the earliest use of psilocybin in mushrooms for medicinal purposes by the ancient Mayans and Aztecs was destroyed by Spanish missionaries in the 1500s. However, that ...

Lupus continues to carry a heavy burden despite advances in immunosuppressive therapy warranting complementary care approaches.